scholarly article | Q13442814 |
P50 | author | Florian Herse | Q47804678 |
Gerd Wallukat | Q63288594 | ||
Ralf Dechend | Q63812628 | ||
P2093 | author name string | Babbette LaMarca | |
Denise C Cornelius | |||
Lorena M Amaral | |||
Mark W Cunningham | |||
Thomas Hünig | |||
Ashlyn C Harmon | |||
Jessica L Faulkner | |||
Tarek Ibrahim | |||
Lukasz Przybyl | |||
P2860 | cites work | Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice | Q33413095 |
Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases | Q34461477 | ||
Sequential induction of effector function, tissue migration and cell death during polyclonal activation of mouse regulatory T-cells | Q34505124 | ||
Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway | Q34681642 | ||
Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes | Q35029700 | ||
CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy | Q35130793 | ||
Pre-eclampsia: pathophysiology, diagnosis, and management | Q35141777 | ||
17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model | Q35151065 | ||
Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction | Q35576417 | ||
Preeclampsia: multiple approaches for a multifactorial disease | Q35665007 | ||
Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats | Q35994304 | ||
An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia | Q36339336 | ||
Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia | Q36380482 | ||
The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia | Q36997267 | ||
Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction | Q37022723 | ||
Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia | Q37079628 | ||
The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia | Q37088970 | ||
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
Regulatory T cells ameliorate intrauterine growth retardation in a transgenic rat model for preeclampsia | Q37451538 | ||
Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy | Q37507162 | ||
Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis | Q42234572 | ||
Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08. | Q42246343 | ||
Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. | Q43862995 | ||
Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome | Q45840291 | ||
Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia | Q46332630 | ||
Endothelial dysfunction in preeclampsia | Q47879591 | ||
Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. | Q54661322 | ||
Effect of CD28 antibody on T cells from patients with systemic lupus erythematosus | Q72625249 | ||
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
IL-6 and TNFalpha across the umbilical circulation in term pregnancies: relationship with labour events | Q82972915 | ||
Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension | Q83799951 | ||
P433 | issue | 5 | |
P577 | publication date | 2017-07-06 | |
P1433 | published in | American Journal of Reproductive Immunology | Q15761228 |
P1476 | title | Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy | |
P478 | volume | 78 |
Q88219951 | Complementing T Regulatory Cells to Combat Hypertension |
Q56516533 | Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study |
Q50420689 | Developmental origins of non-alcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. |
Q92003862 | Nicotinamide and Demographic and Disease transitions: Moderation is Best |
Q48523077 | Preeclampsia: From Inflammation to Immunoregulation |
Q104137018 | Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction |
Q52715243 | The Role of Interleukin-10 in the Pathophysiology of Preeclampsia. |
Search more.